Clinical Trial Update: Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients [Phase 3]

View source ↗

Summary

This update notes the termination of a Phase 3 trial evaluating ribavirin to prevent RSV pneumonia in bone marrow transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Respiratory Syncytial Virus Infections | Phase 3 | Status: TERMINATED